Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026
At ASM Microbe 2026, Bruker Corporations (Nasdaq: BRKR) Microbiology & Infection Diagnostics (BMID) division is demonstrating its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster...